The legal focus is whether the alleged health risks were foreseeable, whether they were adequately disclosed, and whether an individual patients records support a drug-related injury theory based on timing, diagnosis, and documented treatment
It carries a boxed warning regarding the risk of thyroid C-cell tumors observed in rodents, and it should not be used in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Zhou M, Yin Z, Xu J, Wang S, Liao T, Wang K, et al
BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
The timing of when you remember your missed dose determines whether you should take it late or wait for your next scheduled injection